US FDA approves Lilly's Mounjaro to reduce cardiovascular risk
LLY•FDA approves Mounjaro for cardiovascular risk reduction
Eli Lilly said on Friday the U.S. FDA has approved its diabetes drug Mounjaro to lower the risk of major adverse cardiovascular events in adults with type 2 diabetes who are at high risk for these events.
